0000899866-15-000201.txt : 20151130 0000899866-15-000201.hdr.sgml : 20151130 20151130174226 ACCESSION NUMBER: 0000899866-15-000201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151125 FILED AS OF DATE: 20151130 DATE AS OF CHANGE: 20151130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELL LEONARD CENTRAL INDEX KEY: 0001231949 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 151260818 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 wf-form4_144892333569058.xml FORM 4 X0306 4 2015-11-25 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231949 BELL LEONARD C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 1 0 0 0 Common Stock, par value $.0001 per share 2015-11-25 4 M 0 35000 22.90 A 954088 D Common Stock, par value $.0001 per share 2015-11-25 4 S 0 5601 180.29 D 948487 D Common Stock, par value $.0001 per share 2015-11-25 4 S 0 7774 181.47 D 940713 D Common Stock, par value $.0001 per share 2015-11-25 4 S 0 21125 182.45 D 919588 D Common Stock, par value $.0001 per share 2015-11-25 4 S 0 500 182.96 D 919088 D Option to Purchase Common Stock 22.9 2015-11-25 4 M 0 35000 0 D 2010-04-28 2020-01-28 Common Stock, par value $.0001 per share 35000.0 328950 D This transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $179.90 - $180.90. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $180.92 - $181.92. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $181.94 - $182.94. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $182.94 - $183.94. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Michael Greco, Attorney-in-Fact for Leonard Bell 2015-11-30